CN100376255C - 具有抗炎活性和抗动脉粥样硬化活性的藿香提取物以及含有从所述提取物中分离和提纯的椴素的组合物 - Google Patents

具有抗炎活性和抗动脉粥样硬化活性的藿香提取物以及含有从所述提取物中分离和提纯的椴素的组合物 Download PDF

Info

Publication number
CN100376255C
CN100376255C CNB018230695A CN01823069A CN100376255C CN 100376255 C CN100376255 C CN 100376255C CN B018230695 A CNB018230695 A CN B018230695A CN 01823069 A CN01823069 A CN 01823069A CN 100376255 C CN100376255 C CN 100376255C
Authority
CN
China
Prior art keywords
extract
active ingredient
pharmaceutical composition
activity
huoxiang
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB018230695A
Other languages
English (en)
Chinese (zh)
Other versions
CN1518454A (zh
Inventor
李炯圭
吴世洋
安境燮
崔顺子
金正姬
吴九泽
弘廷宙
朴成圭
南穷佑
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea Research Institute of Bioscience and Biotechnology KRIBB
Original Assignee
Korea Research Institute of Bioscience and Biotechnology KRIBB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Research Institute of Bioscience and Biotechnology KRIBB filed Critical Korea Research Institute of Bioscience and Biotechnology KRIBB
Publication of CN1518454A publication Critical patent/CN1518454A/zh
Application granted granted Critical
Publication of CN100376255C publication Critical patent/CN100376255C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/532—Agastache, e.g. giant hyssop
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
CNB018230695A 2001-02-27 2001-12-20 具有抗炎活性和抗动脉粥样硬化活性的藿香提取物以及含有从所述提取物中分离和提纯的椴素的组合物 Expired - Fee Related CN100376255C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR2001/9977 2001-02-27
KR20010009977 2001-02-27

Publications (2)

Publication Number Publication Date
CN1518454A CN1518454A (zh) 2004-08-04
CN100376255C true CN100376255C (zh) 2008-03-26

Family

ID=19706307

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB018230695A Expired - Fee Related CN100376255C (zh) 2001-02-27 2001-12-20 具有抗炎活性和抗动脉粥样硬化活性的藿香提取物以及含有从所述提取物中分离和提纯的椴素的组合物

Country Status (8)

Country Link
US (2) US20040071792A1 (OSRAM)
EP (1) EP1363648B8 (OSRAM)
JP (1) JP4091436B2 (OSRAM)
KR (1) KR100447948B1 (OSRAM)
CN (1) CN100376255C (OSRAM)
CA (1) CA2439430C (OSRAM)
DE (1) DE60124591T2 (OSRAM)
WO (1) WO2002074320A1 (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060003030A1 (en) * 2004-07-01 2006-01-05 Lin Chun-Ying Essential oils for treating and/ or preventing allergic disease
KR100807645B1 (ko) * 2006-10-17 2008-02-28 주식회사 유니젠 위장질환 치료 및 예방용 조성물 및 그의 제조방법
KR100851489B1 (ko) * 2006-11-30 2008-08-08 (주)아모레퍼시픽 틸리아닌( ｔｉｌｉａｎｉｎ) 또는아카세틴(ａｃａｃｅｔｉｎ)을 유효성분으로 함유하는화장료 조성물
DE202008011721U1 (de) * 2008-09-03 2008-12-24 American Phoenix Biotech Inc., Hacienda Heights Pflanzliche Zusammensetzung zur Behandlung von Krebs
KR101540310B1 (ko) * 2013-08-07 2015-07-30 건국대학교 산학협력단 방아풀 추출물을 함유하는 신경 염증 예방 및 치료용 조성물, 그리고 방아풀 추출물 추출 방법
KR20160084820A (ko) * 2015-01-06 2016-07-14 권영아 루테리온 및 그 분리·배양방법
PL412214A1 (pl) 2015-05-04 2016-11-07 Biovico Spółka Z Ograniczoną Odpowiedzialnością Kompozycja roślinna o właściwościach przeciwzapalnych, przeciwalergicznych i/lub przeciwastmatycznych oraz jej zastosowanie
KR102049875B1 (ko) 2018-06-29 2019-11-28 충북대학교 산학협력단 에키나세아 배양근 유래 신규 화합물 및 이의 항염증 용도
CN111171094B (zh) * 2018-11-13 2023-06-16 上海医药工业研究院有限公司 一种香清兰苷中间体及其制备方法和应用
KR102167238B1 (ko) * 2019-05-23 2020-10-19 한국한의학연구원 곽향 추출물을 유효성분으로 함유하는 파골세포 억제용 조성물 및 이의 용도
KR102339923B1 (ko) * 2019-11-12 2021-12-20 한국한의학연구원 혈행 개선용 식치제호탕 조성물
KR102300732B1 (ko) * 2020-11-11 2021-09-14 주식회사 제이에스무역 난황유 및 배초향 줄기세포를 함유하는 항산화, 미백, 항주름 또는 항염증용 조성물
JP2025143197A (ja) * 2024-03-18 2025-10-01 ペガヴィジョン コーポレーション 皮膚バリア強化及び抗炎症用のカワミドリエキソソーム組成物及びその用途

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1060772A (zh) * 1991-10-30 1992-05-06 阳山县食品厂 一种藿香姜计陈皮的生产工艺
CN1089853A (zh) * 1993-01-22 1994-07-27 马军营 小儿速效疫泻灵口服液及制备方法
CN1117388A (zh) * 1994-08-24 1996-02-28 东营市面粉厂 复方柴胡擦剂
CN1151881A (zh) * 1995-12-01 1997-06-18 陶周行 一种阴道冲洗保留剂及其制备工艺与使用方法
CN1280773A (zh) * 2000-08-09 2001-01-24 郭兴华 天然抗菌组合物及其应用
CN1282537A (zh) * 2000-08-22 2001-02-07 张益� 一种藿香饮料

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3831196A1 (de) * 1988-09-14 1990-03-22 Bosch Gmbh Robert Elektromagnetisch betaetigbares ventil
JPH08176002A (ja) * 1994-12-27 1996-07-09 Kao Corp 細胞接着抑制剤
KR970007366A (ko) * 1995-07-31 1997-02-21 고제섭 압축단자 접촉저항 측정장치 및 그 방법
CN1275914A (zh) * 1996-09-27 2000-12-06 刈田毅 以除去自由基为目的的抗氧化组合物、含有该组合物的药物组合物及其制造方法
US5776462A (en) * 1996-12-10 1998-07-07 Sage R&D, A Partnership Pogostemon cablin extract for inhibiting H. influenzae adhesion and treating otitis media or sore throat
KR100232053B1 (ko) * 1997-04-22 1999-12-01 김동태 DPPH(1,1-diphenyl-2-picrylhydrazyl)를 이용한 항산화물질의 분석방법
JP4231559B2 (ja) * 1997-04-23 2009-03-04 オリザ油化株式会社 リポキシゲナーゼ阻害剤
KR100215400B1 (ko) * 1997-05-27 1999-08-16 김진수 건강보조식품용 유중수적형 영양음료 및 그 제조방법
KR100309071B1 (ko) * 1998-09-02 2001-12-17 성재갑 콜라겐합성촉진제를함유한피부용조성물
KR100341798B1 (ko) * 1999-08-04 2002-06-26 대한민국 (관리청:특허청장, 승계청:농촌진흥청장) 방아잎으로부터 로즈마린산을 분리하는 방법
WO2001045725A2 (en) * 1999-12-23 2001-06-28 Ancile Pharmaceuticals, Inc. Treatment for inflammatory bowel disease (ibd) and related conditions
KR100376306B1 (ko) * 2000-08-07 2003-03-17 한완석 혈액순환 촉진용 건강식품 조성물

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1060772A (zh) * 1991-10-30 1992-05-06 阳山县食品厂 一种藿香姜计陈皮的生产工艺
CN1089853A (zh) * 1993-01-22 1994-07-27 马军营 小儿速效疫泻灵口服液及制备方法
CN1117388A (zh) * 1994-08-24 1996-02-28 东营市面粉厂 复方柴胡擦剂
CN1151881A (zh) * 1995-12-01 1997-06-18 陶周行 一种阴道冲洗保留剂及其制备工艺与使用方法
CN1280773A (zh) * 2000-08-09 2001-01-24 郭兴华 天然抗菌组合物及其应用
CN1282537A (zh) * 2000-08-22 2001-02-07 张益� 一种藿香饮料

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
中国卫生部规定69种属食品和良药的动植物. 智欧洲.医学信息，第8卷第2期. 1995 *
藿香根的化学研究. 药学 学报，第26卷第12期. 1991 *

Also Published As

Publication number Publication date
EP1363648A4 (en) 2005-02-09
US7534456B2 (en) 2009-05-19
DE60124591T2 (de) 2007-09-06
JP2004521933A (ja) 2004-07-22
EP1363648A1 (en) 2003-11-26
CA2439430A1 (en) 2002-09-26
CA2439430C (en) 2010-06-22
KR20020070062A (ko) 2002-09-05
CN1518454A (zh) 2004-08-04
US20040071792A1 (en) 2004-04-15
EP1363648B1 (en) 2006-11-15
DE60124591D1 (de) 2006-12-28
EP1363648B8 (en) 2007-04-25
US20080081081A1 (en) 2008-04-03
KR100447948B1 (ko) 2004-09-08
WO2002074320A1 (en) 2002-09-26
JP4091436B2 (ja) 2008-05-28

Similar Documents

Publication Publication Date Title
US7534456B2 (en) Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatory activity and anti-atherogenic activity
US10300092B2 (en) Bee bloom compositions, methods of extraction and uses thereof
Abdel-Moez et al. Evaluating anthelmintic, anti-platelet, and anti-coagulant activities, and identifying the bioactive phytochemicals of Amaranthus blitum L.
KR100865513B1 (ko) 강화약쑥 알코올 추출물을 포함하는 비만의 예방 및 치료용 조성물
JPH04352726A (ja) 動脈硬化防止剤及び動脈硬化防止作用を有する機能性食品
JP5706142B2 (ja) フユボダイジュ花のエタノール抽出物を有効成分とする血中グルコース低下剤、内臓脂肪蓄積抑制剤、ｔｇ低下剤、糞中脂肪排泄促進剤
Mohammed et al. Evaluation of the effect of aqueous leaf extract of jute mallow Corchorus olitorius on some biochemical parameters in alloxan-induced diabetic rats
KR101152479B1 (ko) 탈지된 녹차씨 추출물을 유효성분으로 포함하는 항염 또는 항암 조성물
CN101588810B (zh) 用于治疗和预防炎性疾病的包括络石藤和日本鹿蹄草提取物的组合物
KR20070108291A (ko) 알레르기 증상의 예방 또는 개선 작용을 갖는 음식물 및당해 음식물의 제조방법
KR100460439B1 (ko) 배초향 추출물이 함유된 식품첨가제
JPH01299224A (ja) コレステロール排泄促進剤及びコレステロール排泄促進飲食物
KR20110138732A (ko) 참죽나무 추출물을 함유하는 항염증 조성물
JP2010105922A (ja) Ｌｏｘ−１アンタゴニスト作用剤
KR101606645B1 (ko) 다우리놀 화합물을 유효성분으로 포함하는 면역질환의 예방 및 치료용 조성물
JP2001258505A (ja) 食品組成物
KR102610157B1 (ko) 마르멜로 추출물을 포함하는 비만 예방 또는 치료용 약학적 조성물
Majeed et al. Study the anti-inflammatory activity of artichoke (cynara scolymus) different extracts in experimentel models of acute inflammation in rats
JP5002588B2 (ja) 動脈硬化抑制剤
JP2009275026A (ja) 膵臓リパーゼ活性阻害作用を有する組成物
US20230144344A1 (en) Composition for preventing or treating cardiovascular and metabolic diseases comprising elaeocarpus petiolatus
KR20160084990A (ko) 아까시나무 추출물을 함유하는 동맥경화증, 심근경색, 뇌졸중, 혈관성치매, 간질환, 이상지질혈증 또는 혈전증 예방 또는 치료용 조성물
Zawawi Effect of Strobilanthes crispus extract and individual polyphenols on lipolysis
Lee et al. Research Article Antiatherogenic Effect of Camellia japonica Fruit Extract in High Fat Diet-Fed Rats
KR20180042140A (ko) 은행종자 추출물을 포함하는 혈행개선 및 비만 치료용 조성물

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080326

Termination date: 20181220